Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2007 1
2009 1
2010 2
2011 2
2012 2
2013 2
2014 2
2015 1
2016 2
2017 3
2018 4
2019 2
2020 5
2021 7
2022 3
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Leukocytapheresis in rheumatoid arthritis.
Hidaka T, Hashiba Y, Kubo K, Kai Y, Maeda K. Hidaka T, et al. Transfus Apher Sci. 2017 Oct;56(5):698-702. doi: 10.1016/j.transci.2017.08.017. Epub 2017 Aug 30. Transfus Apher Sci. 2017. PMID: 28918917 Review.
Leukocytapheresis for rheumatic disease.
Hidaka T, Suzuki K. Hidaka T, et al. Ther Apher Dial. 2003 Apr;7(2):161-4. doi: 10.1046/j.1526-0968.2003.00031.x. Ther Apher Dial. 2003. PMID: 12918938 Review.
Late-onset rheumatoid arthritis registry study, LORIS study: study protocol and design.
Kojima M, Kawahito Y, Sugihara T, Kojima T, Harada R, Hirata S, Hashimoto M, Hidaka T, Ishikawa H, Ito H, Kishimoto M, Kaneko Y, Matsui K, Matsui T, Matsushita I, Morinobu A, Nishida K, Tanaka E, Abe A, Ishitoku M, Asai S, Kida T, Onishi A, Takanashi S, Harigai M. Kojima M, et al. Among authors: hidaka t. BMC Rheumatol. 2022 Dec 26;6(1):90. doi: 10.1186/s41927-022-00322-7. BMC Rheumatol. 2022. PMID: 36567352 Free PMC article.
The Japanese Society for Apheresis clinical practice guideline for therapeutic apheresis.
Abe T, Matsuo H, Abe R, Abe S, Asada H, Ashida A, Baba A, Eguchi K, Eguchi Y, Endo Y, Fujimori Y, Furuichi K, Furukawa Y, Furuya M, Furuya T, Hanafusa N, Hara W, Harada-Shiba M, Hasegawa M, Hattori N, Hattori M, Hidaka S, Hidaka T, Hirayama C, Ikeda S, Imamura H, Inoue K, Ishizuka K, Ishizuka K, Ito T, Iwamoto H, Izaki S, Kagitani M, Kaneko S, Kaneko N, Kanekura T, Kitagawa K, Kusaoi M, Lin Y, Maeda T, Makino H, Makino S, Matsuda K, Matsugane T, Minematsu Y, Mineshima M, Miura K, Miyamoto K, Moriguchi T, Murata M, Naganuma M, Nakae H, Narukawa S, Nohara A, Nomura K, Ochi H, Ohkubo A, Ohtake T, Okada K, Okado T, Okuyama Y, Omokawa S, Oji S, Sakai N, Sakamoto Y, Sasaki S, Sato M, Seishima M, Shiga H, Shimohata H, Sugawara N, Sugimoto K, Suzuki Y, Suzuki M, Tajima T, Takikawa Y, Tanaka S, Taniguchi K, Tsuchida S, Tsukamoto T, Tsushima K, Ueda Y, Wada T, Yamada H, Yamada H, Yamaka T, Yamamoto K, Yokoyama Y, Yoshida N, Yoshioka T, Yamaji K. Abe T, et al. Among authors: hidaka t. Ther Apher Dial. 2021 Dec;25(6):728-876. doi: 10.1111/1744-9987.13749. Ther Apher Dial. 2021. PMID: 34877777
High incidence of serious infections requiring hospitalisation in human T-cell leukaemia virus type 1-positive rheumatoid arthritis: A case-controlled observational study.
Hashiba Y, Umekita K, Kimura M, Iwao C, Iwao K, Kariya Y, Kubo K, Miyauchi S, Kudou R, Rikitake Y, Kawaguchi T, Matsuda M, Takajo I, Inoue E, Hidaka T, Okayama A. Hashiba Y, et al. Among authors: hidaka t. Mod Rheumatol. 2022 Aug 20;32(5):866-874. doi: 10.1093/mr/roab077. Mod Rheumatol. 2022. PMID: 34897491
HAS-Flow May Be an Adequate Method for Evaluating Human T-Cell Leukemia Virus Type 1 Infected Cells in Human T-Cell Leukemia Virus Type 1-Positive Rheumatoid Arthritis Patients Receiving Antirheumatic Therapies: A Retrospective Cross-Sectional Observation Study.
Umekita K, Hashikura Y, Takaki A, Kimura M, Kawano K, Iwao C, Miyauchi S, Kawaguchi T, Matsuda M, Hashiba Y, Hidaka T. Umekita K, et al. Among authors: hidaka t. Viruses. 2023 Feb 8;15(2):468. doi: 10.3390/v15020468. Viruses. 2023. PMID: 36851682 Free PMC article.
Non-TNF inhibitor switchers versus TNF inhibitor cyclers from multicentre rheumatoid arthritis ultrasonography prospective cohort in Japan.
Endo Y, Kawashiri SY, Morimoto S, Nishino A, Okamoto M, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Koga T, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Ueki Y, Yoshitama T, Eiraku N, Matsuoka N, Okada A, Fujikawa K, Hamada H, Tsuru T, Nagano S, Arinobu Y, Hidaka T, Tada Y, Kawakami A. Endo Y, et al. Among authors: hidaka t. Immunol Med. 2020 Sep;43(3):115-120. doi: 10.1080/25785826.2020.1757920. Epub 2020 May 12. Immunol Med. 2020. PMID: 32393150
Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis.
Nozaki Y, Hidaka T, Ri J, Itami T, Tomita D, Okada A, Ashida C, Ikeda F, Yamamoto A, Funahashi K, Kinoshita K, Matsubara T, Funauchi M, Matsumura I. Nozaki Y, et al. Among authors: hidaka t. Front Med (Lausanne). 2021 Apr 21;8:643459. doi: 10.3389/fmed.2021.643459. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33968956 Free PMC article.
41 results